Blood Safety
HTLV-I/II inactivated in blood products by photochemical inactivation
Published in AIDS Weekly, September 12th, 2005
"Human T-cell leukemia virus Types I and II (HTLV-I and HTLV-II), blood-borne retroviruses found worldwide, can cause leukemia, immunosuppression, and severe neurologic diseases. In most countries, HTLV-I and -II screening is not performed systematically for blood donations," investigators in France report.
"A new photochemical treatment (PCT) with a synthetic psoralen was developed to inactivate most pathogens in platelet (PLT) concentrates or plasma and to improve the safety of blood donations," wrote V. Jauvin and colleagues at the University of Bordeaux.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-09-12)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
HIV-1 RNA from dried-blood spot samples correlates with plasma viral load - HIV/AIDS Exposure
CD91 expression increased on monocytes of exposed/HIV-1-seronegative subjects - HIV/AIDS Postexposure Prophylaxis
HIV postexposure prophylaxis not routinely offered following sexual assault - HIV/AIDS Research
Biological assay system demonstrates human retroviral protease activity - HIV/AIDS Screening
HIV infection detected in emergency department screening in low prevalence area - Angiosarcoma
Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
